Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction
progenitor cells、clinical use、drug target
27
R3 ;R97
MB was partially supported by the NIH Biodefense and Emerging Infectious Disease training grant AI055429.CFQ was supported by the National Natural Science Foundation of China NSFC Excellent Young Scientist81522025;Innovative Research Group81621005;the National Key Research and Development Project of China2016YFD0500304;the National Science and Technology Major Project of China2017ZX09101005;the Newton Advanced Fellowship from the UK Academy of Medical SciencesNAF0031003;the NSFC 81661130162.BL was partially supported by a visiting scholarship sponsored by Guangdong Ocean University.FG was partially supported by a visiting scholarship sponsored by the China Scholarship Council.This work was partially supported by the Wadsworth Center flavivirus drug discovery seed;by NIH grant DA038446;by the Intramural Research Program of NCATS,NIH
2017-09-15(万方平台首次上网日期,不代表论文的发表时间)
共19页
1046-1064